의료비 상환 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년) - 청구액별, 지불자별, 서비스 제공업체별, 지역별, 기업별

Healthcare Reimbursement Market - Global Healthcare Reimbursement Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Claim Coverage, By Payer Coverage, By Service Provider Coverage, By Geographic Coverage and By Company)

US $ 4,995 ￦ 7,055,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 11,999,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,972,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

의료비 상환 시장 규모는 비약적인 성장을 앞두고 있습니다. 2022년에는 112억 달러로, 2023년부터 2030년까지 연평균 성장률(CAGR)이 18.2%에 달해 2030년에는 361억 달러에 달할 것으로 예상됩니다.

이러한 전례 없는 성장세를 뒷받침하는 주요 요인 중 하나는 헬스케어 애플리케이션의 인기가 높아지고 있다는 점입니다. 전자 의료 기록(EHR), 원격의료, 데이터 분석과 같은 기술 혁신은 효율성과 정확성을 향상시킴으로써 상환 프로세스에 혁명을 일으키고 있습니다. 이러한 발전은 청구 처리를 간소화하고, 오류를 줄이며, 투명한 청구 업무를 보장함으로써 혁신적인 상환 솔루션에 대한 수요를 촉진하고 있습니다.

또한, 의료비 상승과 만성질환의 유병률 증가는 시장 확대에 크게 기여하고 있습니다. 의료비가 지속적으로 증가함에 따라 효율적이고 투명한 상환 프로세스에 대한 수요가 증가하고 있습니다. 따라서 만성질환 환자들에게 적시에 적절한 치료를 제공하면서도 비용을 효과적으로 관리할 수 있는 혁신적인 상환 모델과 가치 기반 치료 전략을 개발해야 합니다.

이 보고서는 세계 의료비 상환 시장에 대해 조사했으며, 시장 개요와 함께 청구액별, 지불자별, 서비스 제공자별, 지역별, 기업별 동향, 시장 진입 기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 의료비 상환 시장 전망, 2018-2030년

• 세계의 의료비 상환 시장 전망, 청구액별(10억 달러), 2018-2030년
• 세계의 의료비 상환 시장 전망, 지불자별, 금액(10억 달러), 2018-2030년
• 세계의 의료비 상환 시장 전망, 서비스 프로바이더별, 금액(10억 달러), 2018-2030년
• 세계의 의료비 상환 시장 전망, 지역별, 금액(10억 달러), 2018-2030년

제4장 북미의 의료비 상환 시장 전망, 2018-2030년

제5장 유럽의 의료비 상환 시장 전망, 2018-2030년

제6장 아시아태평양의 의료비 상환 시장 전망, 2018-2030년

제7장 라틴아메리카의 의료비 상환 시장 전망, 2018-2030년

제8장 중동 및 아프리카의 의료비 상환 시장 전망, 2018-2030년

제9장 경쟁 상황

• 서비스 프로바이더와 청구액 히트맵
• 기업 시장 점유율 분석, 2022년
• 경쟁 대시보드
• 기업 개요
  • UnitedHealth Group
  • Anthem, Inc.
  • Cigna
  • Humana Inc.
  • Blue Cross Blue Shield Association
  • Centene Corporation
  • Molina Healthcare
  • Kaiser Permanente
  • CVS Health
  • Tenet Healthcare
  • HCA Healthcare
  • Magellan Health
  • Universal American
  • Gateway Health The Joint Commission

제10장 부록

ksm

영문 목차

영문목차

Healthcare reimbursement market is set to experience exponential growth, according to the latest report by [Your Company/Institution]. With an estimated worth of US$11.2 billion in 2022, the market is forecasted to soar to US$36.1 billion by 2030, reflecting a staggering Compound Annual Growth Rate (CAGR) of 18.2% during the period of 2023 to 2030.

Fueling Factors Behind Growth

Advancements in Healthcare Technology

One of the primary drivers behind this unprecedented growth trajectory is the increasing popularity of healthcare applications. Technological innovations, including electronic health records (EHRs), telemedicine, and data analytics, are revolutionizing reimbursement processes by enhancing efficiency and accuracy. These advancements streamline claims processing, reduce errors, and ensure transparent billing practices, thereby driving the demand for innovative reimbursement solutions.

Rising Healthcare Expenditure and Chronic Disease Prevalence

Moreover, rising healthcare costs coupled with the increasing prevalence of chronic diseases are significant contributors to market expansion. As healthcare expenses continue to escalate, there is a growing demand for efficient and transparent reimbursement processes. This necessitates the development of innovative reimbursement models and value-based care strategies to manage costs effectively while ensuring timely and appropriate care for patients with chronic conditions.

Key Trends and Opportunities

Telehealth Integration

Telehealth integration emerges as a pivotal trend in the healthcare reimbursement market, facilitating accurate billing and payment processes for virtual healthcare services. By automating claims submission and supporting transparent billing practices, telehealth integration ensures efficient reimbursement in the evolving healthcare landscape.

Electronic Health Records (EHRs) and Robotic Process Automation (RPA)

Integration of EHR systems and RPA technology further optimizes reimbursement workflows by enhancing data accuracy and automating repetitive tasks. These innovations reduce administrative burdens and accelerate reimbursement processes, ultimately driving market growth.

Challenges and Opportunities

Complex Regulations and Administrative Burden

However, the market faces challenges due to complex regulations and administrative burdens. Navigating intricate compliance requirements and evolving regulatory landscapes requires continuous training and technology updates. Streamlining administrative tasks through automation and improved technology presents an opportunity to alleviate this challenge and enhance reimbursement efficiency.

Regional Dynamics

North America's Leadership and Asia Pacific's Growth Prospects

North America leads the global healthcare reimbursement market, driven by its advanced healthcare infrastructure and extensive insurance coverage. In contrast, Asia Pacific witnesses rapid growth fueled by increasing healthcare investments and expanding insurance coverage. The adoption of advanced technologies and evolving reimbursement policies align with the region's modernization efforts, making it a dynamic and rapidly expanding market.

Competitive Landscape

Leaders in the Global Healthcare Reimbursement Market

The market is dominated by key players such as Magellan Health, UnitedHealth Group, Anthem, Inc., Cigna, and Humana Inc. These companies are introducing new products and enhancing distribution channels to consolidate their global presence. More consolidation is expected in the coming years, further shaping the competitive landscape of the healthcare reimbursement market.

Global Healthcare Reimbursement Market is Segmented as Below:

By Claim:

• Fully Paid
• Underpaid

By Payer:

• Private Payers
• Public Payers

By Service Provider:

• Physician Office
• Hospitals
• Diagnostic Laboratories
• Others

By Geographic Coverage:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Turkey
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Egypt
  • Nigeria
  • Rest of the Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Healthcare Reimbursement Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2022
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. Covid-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Healthcare Reimbursement Market Outlook, 2018 - 2030

• 3.1. Global Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 3.1.1. Key Highlights
    • 3.1.1.1. Fully Paid
    • 3.1.1.2. Underpaid
• 3.2. Global Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 3.2.1. Key Highlights
    • 3.2.1.1. Private Payers
    • 3.2.1.2. Public Payers
• 3.3. Global Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 3.3.1. Key Highlights
    • 3.3.1.1. Physician Office
    • 3.3.1.2. Hospitals
    • 3.3.1.3. Diagnostic Laboratories
    • 3.3.1.4. Others
• 3.4. Global Healthcare Reimbursement Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
  • 3.4.1. Key Highlights
    • 3.4.1.1. North America
    • 3.4.1.2. Europe
    • 3.4.1.3. Asia Pacific
    • 3.4.1.4. Latin America
    • 3.4.1.5. Middle East & Africa

4. North America Healthcare Reimbursement Market Outlook, 2018 - 2030

• 4.1. North America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 4.1.1. Key Highlights
    • 4.1.1.1. Fully Paid
    • 4.1.1.2. Underpaid
• 4.2. North America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 4.2.1. Key Highlights
    • 4.2.1.1. Private Payers
    • 4.2.1.2. Public Payers
• 4.3. North America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 4.3.1. Key Highlights
    • 4.3.1.1. Physician Office
    • 4.3.1.2. Hospitals
    • 4.3.1.3. Diagnostic Laboratories
    • 4.3.1.4. Others
  • 4.3.2. BPS Analysis/Market Attractiveness Analysis
• 4.4. North America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 4.4.1. Key Highlights
    • 4.4.1.1. U.S. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 4.4.1.2. U.S. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 4.4.1.3. U.S. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 4.4.1.4. U.S. Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
    • 4.4.1.5. Canada Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 4.4.1.6. Canada Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 4.4.1.7. Canada Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 4.4.1.8. Canada Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
  • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Healthcare Reimbursement Market Outlook, 2018 - 2030

• 5.1. Europe Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 5.1.1. Key Highlights
    • 5.1.1.1. Fully Paid
    • 5.1.1.2. Underpaid
• 5.2. Europe Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 5.2.1. Key Highlights
    • 5.2.1.1. Private Payers
    • 5.2.1.2. Public Payers
• 5.3. Europe Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 5.3.1. Key Highlights
    • 5.3.1.1. Physician Office
    • 5.3.1.2. Hospitals
    • 5.3.1.3. Diagnostic Laboratories
    • 5.3.1.4. Others
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis
• 5.4. Europe Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 5.4.1. Key Highlights
    • 5.4.1.1. Germany Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.2. Germany Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.3. Germany Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.4. U.K. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.5. U.K. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.6. U.K. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.7. France Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.8. France Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.9. France Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.10. Italy Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.11. Italy Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.12. Italy Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.13. Turkey Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.14. Turkey Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.15. Turkey Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.16. Russia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.17. Russia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.18. Russia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 5.4.1.19. Rest of Europe Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 5.4.1.20. Rest of Europe Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 5.4.1.21. Rest of Europe Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Healthcare Reimbursement Market Outlook, 2018 - 2030

• 6.1. Asia Pacific Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 6.1.1. Key Highlights
    • 6.1.1.1. Fully Paid
    • 6.1.1.2. Underpaid
• 6.2. Asia Pacific Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 6.2.1. Key Highlights
    • 6.2.1.1. Private Payers
    • 6.2.1.2. Public Payers
• 6.3. Asia Pacific Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 6.3.1. Key Highlights
    • 6.3.1.1. Physician Office
    • 6.3.1.2. Hospitals
    • 6.3.1.3. Diagnostic Laboratories
    • 6.3.1.4. Others
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. Asia Pacific Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 6.4.1. Key Highlights
    • 6.4.1.1. China Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.2. China Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.3. China Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.1.4. Japan Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.5. Japan Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.6. Japan Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.1.7. South Korea Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.8. South Korea Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.9. South Korea Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.1.10. India Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.11. India Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.12. India Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.1.13. Southeast Asia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.14. Southeast Asia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.15. Southeast Asia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 6.4.1.16. Rest of Asia Pacific Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 6.4.1.17. Rest of Asia Pacific Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 6.4.1.18. Rest of Asia Pacific Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Healthcare Reimbursement Market Outlook, 2018 - 2030

• 7.1. Latin America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 7.1.1. Key Highlights
    • 7.1.1.1. Fully Paid
    • 7.1.1.2. Underpaid
• 7.2. Latin America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 7.2.1. Key Highlights
    • 7.2.1.1. Private Payers
    • 7.2.1.2. Public Payers
• 7.3. Latin America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 7.3.1. Key Highlights
    • 7.3.1.1. Physician Office
    • 7.3.1.2. Hospitals
    • 7.3.1.3. Diagnostic Laboratories
    • 7.3.1.4. Others
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Latin America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 7.4.1. Key Highlights
    • 7.4.1.1. Brazil Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 7.4.1.2. Brazil Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.4.1.3. Brazil Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.4.1.4. Mexico Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 7.4.1.5. Mexico Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.4.1.6. Mexico Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.4.1.7. Argentina Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 7.4.1.8. Argentina Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.4.1.9. Argentina Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 7.4.1.10. Rest of Latin America Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 7.4.1.11. Rest of Latin America Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 7.4.1.12. Rest of Latin America Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Healthcare Reimbursement Market Outlook, 2018 - 2030

• 8.1. Middle East & Africa Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
  • 8.1.1. Key Highlights
    • 8.1.1.1. Fully Paid
    • 8.1.1.2. Underpaid
• 8.2. Middle East & Africa Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
  • 8.2.1. Key Highlights
    • 8.2.1.1. Private Payers
    • 8.2.1.2. Public Payers
• 8.3. Middle East & Africa Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 8.3.1. Key Highlights
    • 8.3.1.1. Physician Office
    • 8.3.1.2. Hospitals
    • 8.3.1.3. Diagnostic Laboratories
    • 8.3.1.4. Others
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Middle East & Africa Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
  • 8.4.1. Key Highlights
    • 8.4.1.1. GCC Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 8.4.1.2. GCC Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.4.1.3. GCC Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.1.4. South Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 8.4.1.5. South Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.4.1.6. South Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.1.7. Egypt Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 8.4.1.8. Egypt Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.4.1.9. Egypt Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.1.10. Nigeria Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 8.4.1.11. Nigeria Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.4.1.12. Nigeria Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
    • 8.4.1.13. Rest of Middle East & Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
    • 8.4.1.14. Rest of Middle East & Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
    • 8.4.1.15. Rest of Middle East & Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. Service Provider vs Claim Heatmap
• 9.2. Company Market Share Analysis, 2022
• 9.3. Competitive Dashboard
• 9.4. Company Profiles
  • 9.4.1. UnitedHealth Group
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Product Portfolio
    • 9.4.1.3. Financial Overview
    • 9.4.1.4. Business Strategies and Development
  • 9.4.2. Anthem, Inc.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Product Portfolio
    • 9.4.2.3. Financial Overview
    • 9.4.2.4. Business Strategies and Development
  • 9.4.3. Cigna
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Product Portfolio
    • 9.4.3.3. Financial Overview
    • 9.4.3.4. Business Strategies and Development
  • 9.4.4. Humana Inc.
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Product Portfolio
    • 9.4.4.3. Financial Overview
    • 9.4.4.4. Business Strategies and Development
  • 9.4.5. Blue Cross Blue Shield Association
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Product Portfolio
    • 9.4.5.3. Financial Overview
    • 9.4.5.4. Business Strategies and Development
  • 9.4.6. Centene Corporation
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Product Portfolio
    • 9.4.6.3. Financial Overview
    • 9.4.6.4. Business Strategies and Development
  • 9.4.7. Molina Healthcare
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Product Portfolio
    • 9.4.7.3. Financial Overview
    • 9.4.7.4. Business Strategies and Development
  • 9.4.8. Kaiser Permanente
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Product Portfolio
    • 9.4.8.3. Financial Overview
    • 9.4.8.4. Business Strategies and Development
  • 9.4.9. CVS Health
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Product Portfolio
    • 9.4.9.3. Financial Overview
    • 9.4.9.4. Business Strategies and Development
  • 9.4.10. Tenet Healthcare
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Product Portfolio
    • 9.4.10.3. Financial Overview
    • 9.4.10.4. Business Strategies and Development
  • 9.4.11. HCA Healthcare
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Product Portfolio
    • 9.4.11.3. Financial Overview
    • 9.4.11.4. Business Strategies and Development
  • 9.4.12. Magellan Health
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Product Portfolio
    • 9.4.12.3. Financial Overview
    • 9.4.12.4. Business Strategies and Development
  • 9.4.13. Universal American
    • 9.4.13.1. Company Overview
    • 9.4.13.2. Product Portfolio
    • 9.4.13.3. Financial Overview
    • 9.4.13.4. Business Strategies and Development
  • 9.4.14. Gateway Health
    • 9.4.14.1. Company Overview
    • 9.4.14.2. Product Portfolio
    • 9.4.14.3. Financial Overview
    • 9.4.14.4. Business Strategies and Development
  • 9.4.15. The Joint Commission
    • 9.4.15.1. Company Overview
    • 9.4.15.2. Product Portfolio
    • 9.4.15.3. Financial Overview
    • 9.4.15.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료